|
|
|
| The Path To Commercialization | Did you miss the 4th Annual Biotech Startup Symposium live event? Here's your chance to catch the on-demand version, including all the industry expert analysis on regulatory considerations, the current state of venture capital, and technical presentations on a variety of real-world technology examples! Learn more. |
|
|
|
|
By Janel Firestein, Clarkston Consulting | There is a great opportunity for clinical supply chain practitioners to learn from their commercial peers. By adapting and adopting the right commercial best practices, clinical supply chains become more effective, cost-efficient, and agile in delivering the right treatments to the right patients. |
|
|
|
|
| Current And Emerging Technologies To Optimize mRNA Manufacturing | Article | By Clemens Jakobi, Michał Domański, and Telmo Graça, Lonza | Learn about the benefits of using mRNA for vaccines and therapeutics, as well as how you can address technical, intellectual property, and cost considerations when considering commercial production. |
|
|
| Building A Fully Single-Use Process With Protein A Membrane Devices | Application Note | By Shunsuke Shiina, Ph.D., Chase Snyder, Neha Saxena, Ph.D., and Rodrigo Gonzalez, Ph.D., W.L. Gore & Associates | Explore results from a study demonstrating the capability of an intensified, single-use downstream process for a fed-batch cell culture harvest producing a representative mAb at an industrial scale. |
|
|
| Reliability Assessments And Benchmarking In Life Sciences | Case Study | By Richard Tree, CAI | Gain insight into how a prominent medical device manufacturer observed a significant improvement in its plant-wide OSHA recordable rate and cost of goods savings of over $100,000/year in just one year. |
|
|
|
| Soluble Versus Insoluble Expression In Microbial Fermentation | Article | By Nikolay Krumov and Jonas Mueller, Lonza | Expression of inclusion bodies has historically suffered a bad reputation in the industry. So, how do these two routes, soluble and insoluble, compare in terms of their advantages and challenges? |
|
|
| Process Transfer Of CHO Cultivations | Application Note | INFORS HT | Explore process engineering characterization results that demonstrate why the Minifors 2 is recommended for CHO cell culture processes and other shear-sensitive cell types. |
|
|
|
|
| Cutting Difficult Targets Down To Size | e-book | Bruker Cellular Analysis | Discover a plasma B discovery workflow that addresses these problems by using cutting-edge single-cell screening technology to revolutionize antibody discovery. |
|
|
|
|
| mRNA Product Purification Process Strategies | Article | Cytiva | Impurities from IVT can induce undesired immune responses and negatively impact translation efficiency. Explore the pros and cons of each option for mRNA purification. |
|
|
| From Nanoformed Powder To 3D Printable Ink | Poster | By Martti Kaasalainen, Katariina Kojo, Niklas Sandler, and Satu Lakio, Nanoform | 3D printing in pharmaceutics is advancing to offer innovative drug delivery applications. Explore the possibilities of forming stable suspensions in printing ink from nanoformed materials. |
|
|
|
|
|
|
| Join The Advancing RNA Community | Introducing Advancing RNA, an online community designed to be a forum and resource for professionals working on RNA-based therapeutics to better understand the challenges that confront them in areas such as analytical/quality, manufacturing, formulation, outsourcing, clinical research, and supply chain/logistics. Sign up for the Advancing RNA newsletter, delivered to your inbox weekly. |
|
|
|
|
|
|
|
|
|
|
|
LIFE SCIENCE LEADER MAGAZINE |
|
|
|
Have you heard of Life Science Leader? Check it out today for access to candid interviews with top-tier executives on how they do business. |
|
|
Connect With Bioprocess Online: |
|
|
|